Abstract: In one example, a semiconductor device can comprise a substrate, a device stack, first and second internal interconnects, and an encapsulant. The substrate can comprise a first and second substrate sides opposite each other, a substrate outer sidewall between the first substrate side and the second substrate side, and a substrate inner sidewall defining a cavity between the first substrate side and the second substrate side. The device stack can be in the cavity and can comprise a first electronic device, and a second electronic device stacked on the first electronic device. The first internal interconnect can be coupled to the substrate and the device stack. The encapsulant can cover the substrate inner sidewall and the device stack and can fill the cavity. Other examples and related methods are disclosed herein.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: A passive optical network system includes an optical line terminator (OLT) configured to detect signal strength and a phase of a burst-mode uplink signal from each of optical network units (ONUs) to control the ONUs so as to equalize signal strengths of signals received from the ONUs and configured to control the ONUs so as to adjust a phase of each of the signals received from the ONUs, and the ONUs are each configured to control signal strength and phase of an burst-mode uplink signal and transmit a resultant burst-mode uplink signal under control of the OLT.

Abstract: The present invention relates to: a novel Lactobacillus intestinalis YT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus intestinalis comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novel Lactobacillus intestinalis strain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reported Lactobacillus intestinalis strains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression.

Abstract: An optical line terminal (OLT) includes: a first optical transceiver and a second optical transceiver each configured to transmit or receive at least one optical signal among an optical signal of a first standard and an optical signal of a second standard through an optical cable inserted thereinto, and convert between an optical signal and an electrical signal; a first connector configured to electrically connect an extended output terminal of an electrical signal input/output unit of the first transceiver and an extended output terminal of an electrical signal input/output unit of the second optical transceiver; and a second connector configured to selectively connect the extended output terminal and a default output terminal of the electrical signal input/output unit of the second optical transceiver.

Abstract: The present invention relates to: a novel Lactobacillus intestinalis YT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus intestinalis comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novel Lactobacillus intestinalis strain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reported Lactobacillus intestinalis strains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression.

Abstract: An optical line terminal (OLT) includes: a first optical transceiver and a second optical transceiver each configured to transmit or receive at least one optical signal among an optical signal of a first standard and an optical signal of a second standard through an optical cable inserted thereinto, and convert between an optical signal and an electrical signal; a first connector configured to electrically connect an extended output terminal of an electrical signal input/output unit of the first transceiver and an extended output terminal of an electrical signal input/output unit of the second optical transceiver; and a second connector configured to selectively connect the extended output terminal and a default output terminal of the electrical signal input/output unit of the second optical transceiver.

Abstract: An optical transceiver of the present invention includes a coexistence element therein. An optical signal according to a first standard and an optical signal according to a second standard are transmitted and received through an optical cable accommodated in a first receptacle of the optical transceiver, and in the coexistence element, the optical signal according to the first standard and the optical signal according to the second standard are divided/combined. Among the divided upstream optical signals, the optical signal according to the first standard is photoelectrically converted in the optical transceiver, and the optical signal according to the second standard is transmitted to the outside through an optical cable accommodated in a second receptacle.

Abstract: A passive optical network system includes an optical line terminator (OLT) configured to detect signal strength and a phase of a burst-mode uplink signal from each of optical network units (ONUs) to control the ONUs so as to equalize signal strengths of signals received from the ONUs and configured to control the ONUs so as to adjust a phase of each of the signals received from the ONUs, and the ONUs are each configured to control signal strength and phase of an burst-mode uplink signal and transmit a resultant burst-mode uplink signal under control of the OLT.

Abstract: Provided is a novel Lactobacillus acidophilus YTI strain (deposition number: KCCM 11808P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus acidophilus comprising the novel strain.

Abstract: The present invention relates to: a novel Lactobacillus intestinalis YT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus intestinalis comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novel Lactobacillus intestinalis strain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reported Lactobacillus intestinalis strains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression.

Abstract: Provided is a novel Lactobacillus acidophilus YTI strain (deposition number: KCCM 11808P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus acidophilus comprising the novel strain.